Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
 Your new post is loading...
Your new post is loading...
Scoop.it!
(2015). Macrophages are critical effectors of antibody therapies for cancer. mAbs: Vol. 7, No. 2, pp. 303-310. Via Krishan Maggon 
|
Scoop.it!
(2015). High contrast tumor imaging with radio-labeled antibody Fab fragments tailored for optimized pharmacokinetics via PASylation. mAbs: Vol. 7, No. 1, pp. 96-109. Via Krishan Maggon
Krishan Maggon 's curator insight,
January 26, 2015 2:49 AM
mAbsVolume 7, Issue 1, 2015 High contrast tumor imaging with radio-labeled antibody Fab fragments tailored for optimized pharmacokinetics via PASylation View full textDownload full textSupplementalOpen accessDOI:10.4161/19420862.2014.985522Claudia T Mendlerab, Lars Friedricha, Iina Laitinenb, Martin Schlapschya, Markus Schwaigerb, Hans-Jürgen Westerc & Arne Skerraad* pages 96-109 Publishing models and article dates explainedReceived: 24 Aug 2014Accepted: 28 Oct 2014Accepted author version posted online: 21 Nov 2014 |
pages 303-310
Publishing models and article dates explainedReceived: 4 Jan 2015Accepted: 15 Jan 2015Accepted author version posted online: 10 Feb 2015Article Views: 321pages 303-310
Publishing models and article dates explainedReceived: 4 Jan 2015Accepted: 15 Jan 2015Accepted author version posted online: 10 Feb 2015Article Views: 321